Driving Change: What the PCC Working Group Has Learned and What’s Next
The Predictable Cost of Care Working Group (the PCC) is a multi-organizational effort comprised of pharmaceutical and biotech manufacturers, pathway vendor organizations, community practices, IDNs, and payers. The purpose of the PCC is to inform pathway developers and practices about a greater span of costs than simply drug costs; provide relevant context in competitive situations; and identify areas for quality improvement, efficiency. In this discussion, Edward Arrowsmith, MD, from Tennessee Oncology provides an update emphasizing how the PCC framework supports value-based care by helping practices account for factors like site-of-service differences, supportive care, and adverse event management—all key to improving outcomes while reducing overall costs.
